Currently, the choice of treatment method for patients with stage II-III esophageal cancer using neoadjuvant chemoradiation therapy is considered justified. This paper presents the results of evaluating the effectiveness of treating locally advanced esophageal cancer using independent remote radiation therapy, as well as competitive chemoradiation therapy.